Patents by Inventor Anne-Ulrike Trendelenburg

Anne-Ulrike Trendelenburg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TGFbeta 2 antibodies
    Patent number: 11180546
    Abstract: This invention is in the field of anti-transforming growth factor beta 2 (TGF-?2) antibodies. In particular, the invention provides human monoclonal antibodies that bind the human TGF-?2 isoform preferentially over the human TGF-?1 or TGF-?3 isoforms.
    Type: Grant
    Filed: February 17, 2017
    Date of Patent: November 23, 2021
    Assignee: NOVARTIS AG
    Inventors: Chikwendu Ibebunjo, Carsten Jacobi, Angelika Meyer, Eveline Schaadt, Anne-Ulrike Trendelenburg, Olga Vladimirovna Mitina
  • TGFbeta 2 Antibodies
    Publication number: 20190092846
    Abstract: This invention is in the field of anti-transforming growth factor beta 2 (TGF-?2) antibodies. In particular, the invention provides human monoclonal antibodies that bind the human TGF-?2 isoform preferentially over the human TGF-?1 or TGF-?3 isoforms.
    Type: Application
    Filed: February 17, 2017
    Publication date: March 28, 2019
    Inventors: Chiwendu IBEBUNJO, Carsten JACOBI, Angelika MEYER, Evenline SCHAADT, Anne-Ulrike TRENDELENBURG, Olga Vladimirovna MATINA
  • Ophthalmic use
    Publication number: 20060142249
    Abstract: The present invention relates to the use of a GABA-C-antagonist in the preparation of a medicament for the treatment of myopia.
    Type: Application
    Filed: June 27, 2003
    Publication date: June 29, 2006
    Inventors: Wolfgang Froestl, Rudolf Markstein, Katrina Schmid, Anne-Ulrike Trendelenburg